5 Stocks Pushing The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 112 points (-0.7%) at 15,897 as of Tuesday, Dec. 3, 2013, 11:45 AM ET. The NYSE advances/declines ratio sits at 970 issues advancing vs. 1,886 declining with 143 unchanged.

The Health Services industry currently sits down 0.1% versus the S&P 500, which is down 0.4%. On the negative front, top decliners within the industry include Grifols ( GRFS), down 1.8%, WellPoint ( WLP), down 1.4%, Agilent Technologies ( A), down 1.0%, Covidien ( COV), down 0.8% and Express Scripts ( ESRX), down 0.6%. A company within the industry that increased today was St Jude Medical ( STJ), up 0.8%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. Stryker Corporation ( SYK) is one of the companies pushing the Health Services industry lower today. As of noon trading, Stryker Corporation is down $0.60 (-0.8%) to $73.66 on light volume. Thus far, 316,630 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $73.63-$74.23 after having opened the day at $74.05 as compared to the previous trading day's close of $74.26.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. Stryker Corporation has a market cap of $28.2 billion and is part of the health care sector. The company has a P/E ratio of 31.9, above the S&P 500 P/E ratio of 17.7. Shares are up 35.5% year to date as of the close of trading on Monday. Currently there are 14 analysts that rate Stryker Corporation a buy, 1 analyst rates it a sell, and 10 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

These Stocks Are Ready to Reverse Course

Don't Get Out of Joint

Zimmer Biomet: Cramer's Top Takeaways

Market Stands at a Make-Or-Break Level: Cramer's 'Mad Money' Recap (Monday 7/17/17)

Analyst Says Rival Bidder Could Emerge for Novadaq After Stryker Deal